iScience (Dec 2022)

Type 2 diabetes is associated with increased circulating levels of 3-hydroxydecanoate activating GPR84 and neutrophil migration

  • Randi Bonke Mikkelsen,
  • Tulika Arora,
  • Kajetan Trošt,
  • Oksana Dmytriyeva,
  • Sune Kjærsgaard Jensen,
  • Abraham Stijn Meijnikman,
  • Louise Elisabeth Olofsson,
  • Dimitra Lappa,
  • Ömrüm Aydin,
  • Jens Nielsen,
  • Victor Gerdes,
  • Thomas Moritz,
  • Arnold van de Laar,
  • Maurits de Brauw,
  • Max Nieuwdorp,
  • Siv Annegrethe Hjorth,
  • Thue Walter Schwartz,
  • Fredrik Bäckhed

Journal volume & issue
Vol. 25, no. 12
p. 105683

Abstract

Read online

Summary: Obesity and diabetes are associated with inflammation and altered plasma levels of several metabolites, which may be involved in disease progression. Some metabolites can activate G protein-coupled receptors (GPCRs) expressed on immune cells where they can modulate metabolic inflammation. Here, we find that 3-hydroxydecanoate is enriched in the circulation of obese individuals with type 2 diabetes (T2D) compared with nondiabetic controls. Administration of 3-hydroxydecanoate to mice promotes immune cell recruitment to adipose tissue, which was associated with adipose inflammation and increased fasting insulin levels. Furthermore, we demonstrate that 3-hydroxydecanoate stimulates migration of primary human and mouse neutrophils, but not monocytes, through GPR84 and Gαi signaling in vitro. Our findings indicate that 3-hydroxydecanoate is a T2D-associated metabolite that increases inflammatory responses and may contribute to the chronic inflammation observed in diabetes.

Keywords